Interestingly, once we look past the very hard sell-off so far... That buying volume is very telling. Seems to me like there are a lot of people seeing this as an opportunity to either average down or accumulate more at these levels.
RSI is on an upwards trend, as well as the OBV which has just ticked into a positive gradient which tells me that there is more buying right now.
For the LTSH's our there, if you can stomach today, our current situation does represent a buying opportunity if you were looking to top up at a discount.
I'm gonna call a rose a rose, and while the CRL was a little disheartening (on the surface value), it is not the end of the road because the FDA, in the Type A meeting, they will definitely need to address the very big ethical issue of doing a randomized trial on kids who are already dying.
Imagine you were a parent who had a kid suffering from acute GVHD. You enrol your child in the trial and your child has a 50% chance of not receiving Rem-L. How would you feel?
This is the issue that the FDA must address.
Hence a conditional accelerated approval pathway is the most ethical way forward!
MSB Price at posting:
$3.40 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)